← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Vitatex, Inc.
Stony Brook, NY
$6,800,246
Total funding
4
Grants
Funding over time
peak $2M · FY2005–16$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$6,800,246 · 4
By mechanism
N43$2,243,431 · 1
R44$2,208,305 · 1
R42$2,171,337 · 1
R41$177,173 · 1
Investigators at Vitatex, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
IGF::OT::IGF TITLE: VITA-CAP TUBE TO PRESERVE CIRCULATING TUMOR CELLS IN BLOOD.$1,952,181
N43 · FY2016 · CA
Cancer Progeniyor Cell Markers$703,024
R44 · FY2012 · CA
Cancer Progeniyor Cell Markers$703,024
R44 · FY2011 · CA
Cancer Progeniyor Cell Markers$702,879
R44 · FY2010 · CA
Cancer detection technology$682,437
R42 · FY2005 · CA
Cancer detection technology$680,986
R42 · FY2006 · CA
Cancer detection technology$630,817
R42 · FY2007 · CA
IGF::OT::IGF TITLE: VITA-CAP TUBE TO PRESERVE CIRCULATING TUMOR CELLS IN BLOOD.$291,250
N43 · FY2015 · CA
Gene Expression of Viable Ovarian Cancer Cells$177,173
R41 · FY2003 · CA
Cancer detection technology$177,097
R42 · FY2004 · CA
Cancer Progeniyor Cell Markers$99,378
R44 · FY2009 · CA